Specialities

Specialities

Bladder Cancer
Breast Cancer
Colorectal Cancer
COVID-19
Dermatological Cancers
Diagnostics and Screening
Gastrointestinal Cancers
Genitourinary Cancer
Gynaecological Cancers
Haematological Malignancies
Haematology
Head and Neck Cancer
Immunotherapy
Leukaemia
Lung Cancer
Lymphoma
Multiple Myeloma
Endocrine Cancers
Ovarian Cancer
Pancreatic Cancer
Paediatric Oncology
Policy
Prostate Cancer
Renal Cancer
Sarcoma
Supportive Cancer Care
Soft Tissue Tumours
Neuro-oncology
Radiology
Radiotherapy
Rare Diseases
Search

Trending Topic
3 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Foreword – touchREVIEWS in Oncology & Haematology, Volume 20, Issue 2, 2024

It is with great pleasure that we present the latest edition of touchREVIEWS in Oncology & Haematology. This issue highlights the remarkable progress and innovation shaping the fields of oncology and haematology, featuring articles that delve into both emerging therapies and the evolving understanding of complex malignancies. We open with an editorial by Mohammad Ammad […]

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin
Haematology
< 1 min

Subnormal Vitamin B12 Concentrations and Anaemia in Older Persons

Wendy PJ den Elzen, Jacobijn Gussekloo
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Jun 3rd 2011 European Oncology & Haematology, 2011;7(2):136-139
Select a Section…
1

Abstract

Overview

Pernicious anaemia is a form of anaemia that is undeniably associated with vitamin B12 deficiency. However, evidence of a positive association between subnormal vitamin B12 concentrations and anaemia in older persons in the general population is limited and inconclusive. Well-designed intervention studies of appropriate size and duration with timely follow-up periods are needed to determine whether subnormal vitamin B12 concentrations are a risk factor for anaemia in older persons in the general population.

Acknowledgement: We thank BioMed Central (BMC Geriatrics, 2010;10:42) and the American Medical Association (Archives of Internal Medicine, 2008;168(20):2241). Copyright © 2008. All rights reserved for granting permission for reproduction of previously published data.

Keywords

Vitamin B12, vitamin B12 deficiency, anaemia, aged

2

Article

Anaemia in Older Persons
Anaemia is very common in older individuals. The reported prevalence ranges from <3% in healthy persons aged 65 years and over to 61% in older patients newly admitted to geriatric wards.1,2 These numbers differ not only because of varying definitions of anaemia, but also because of large differences in study populations with respect to gender, age, race, living situation and health status.1,2 In the Third National Health and Nutrition Examination Survey (NHANES III), a nationally representative study of non-institutionalised civilian adults in the US, the overall prevalence of anaemia among adults aged 65 years and over was 11% in men and 10.2% in women.3 In this study, anaemia was defined according to World Health Organization criteria (haemoglobin concentration less than 12g/dl in women and less than 13g/dl in men).4 Interestingly, the prevalence of anaemia increased significantly with age, up to 26.1% in men and 20.1% in women aged 85 years and over.3

In older persons, anaemia is associated with impaired survival,5–10 decreased physical performance, disability in daily living, cognitive impairment, depression, diminished quality of life and an increased number of hospital admissions.1,11–21 Considering the steep increase in the prevalence of anaemia in older individuals, and the exponential rise in the number of older individuals in our ageing society, anaemia in older individuals may have a significant effect on healthcare needs and costs in the decades to come.22 Adequate diagnosis and treatment of anaemia in older persons is therefore of vital importance.

Vitamin B12 Deficiency in Pernicious Anaemia – An Undeniable Cause of Anaemia
In 1849, Thomas Addison described patients with a ‘very remarkable form of general anaemia’. This severe type of anaemia, for which no treatment was available, was later called anaemia perniciosa (fatal anaemia) by Anton Biermer.23,24 Apart from severe haematological abnormalities, patients with pernicious anaemia also had a sore tongue, neuropathy of the hands and extremities and subacute combined degeneration of the spinal cord.24 After many years of research, it appeared that patients with pernicious anaemia produce antibodies against ‘intrinsic factor’, a molecule in the stomach that is needed to bind and transport vitamin B12 through the gastrointestinal tract.23,24 Therefore, pernicious anaemia is a form of anaemia that is undeniably associated with severe vitamin B12 deficiency. Finding the cure for pernicious anaemia even led to the discovery of vitamin B12.23–29 Undoubtedly, patients with very low vitamin B12 concentrations (in case of pernicious anaemia) have to be treated: several studies showed large increases in haemoglobin after vitamin B12 administration in patients with pernicious anaemia or food vitamin B12 malabsorption.30–34 Subnormal Vitamin B12 Concentration – Also a Cause of Anaemia?
Due to the clear aetiology of pernicious anaemia, the outcomes of studies in patients with pernicious anaemia are often extrapolated to patients with subnormal vitamin B12 concentrations in the general population. As a result, subnormal vitamin B12 concentrations are considered to be associated with (mild) anaemia in general, but also with other conditions such as dementia, neuropathy and subacute combined degeneration of the spinal cord.35–38 Therefore, physicians routinely measure vitamin B12 in patients with anaemia, and individuals with low serum concentrations of vitamin B12 (and normal folate concentrations) are frequently given intramuscular vitamin B12 supplements, often for many years.37–39 Also, since low serum vitamin B12 concentrations are very common in older individuals,40 screening older people for vitamin B12 deficiency has often been recommended.41,42

Although the biological role of vitamin B12 in haematopoiesis is well-defined,38,43–45 current evidence suggests that the outcomes of studies in patients with severe vitamin B12 deficiency should not be extrapolated to patients with subnormal vitamin B12 concentrations in the general population. In the Leiden 85-plus Study, a populationbased prospective follow-up study of 85-year-old individuals in Leiden, The Netherlands, we showed that low vitamin B12 concentrations (<150pmol/l) in 85-year-old subjects are not associated with the presence of anaemia at 85 years of age. The prevalence of anaemia in those with low vitamin B12 concentrations was 29%, and 25% in those with normal vitamin B12 concentrations (p=0.48). There were no differences in haemoglobin concentrations between subjects with low vitamin B12 concentrations and those with normal vitamin B12 concentrations (p=0.59). Also, participants with low vitamin B12 concentrations did not have a higher risk of developing anaemia from age 85 onwards (see Figure 1). Adjustment for possible confounders did not change our results.46

Interestingly, our study did not appear the first to cast doubt on the relationship between subnormal vitamin B12 concentrations and anaemia in older individuals. We performed a systematic review to evaluate the association between subnormal vitamin B12 concentrations and anaemia in older people in the published literature (reprinted with permission by BioMed Central).47 All published crosssectional and longitudinal observational studies in older individuals (mean or median age ≥60 years) on the association between vitamin B12 and anaemia were considered for inclusion in this review. In addition, we considered all randomised controlled trials (RCTs) where subjects 60 years of age and over were treated with vitamin B12 (any dose and any form of administration) and were compared with subjects who were given a placebo. We used pre-defined clinical queries (both sensitive and specific) for aetiology and treatment as provided in PubMed (January 1949–October 2009) and EMBASE (January 1980–October 2009) using relevant Medical Subject Headings (MeSH) and free text words for vitamin B12 and anaemia.

Twenty-one cross-sectional observational studies with a total number of 16,185 participants were included. The studies showed inconsistent results in terms of the association between subnormal vitamin B12 concentrations or vitamin B12 deficiency and anaemia in older subjects. In three out of 21 studies, an association between subnormal vitamin B12 and anaemia was found.48–50 For seven of 21 studies, the presence of an association was not clear because conflicting findings in terms of the presence of an association were reported.51–57 Eleven studies did not find an association between subnormal vitamin B12 and anaemia.58–68 Even in studies that had defined vitamin B12 deficiency using the lowest cut-off points for serum vitamin B12 levels,51,53,55 in which the strongest associations were to be expected, the presence of an association between vitamin B12 deficiency and anaemia was not clear, because conflicting findings regarding the presence of an association were reported. Similar inconsistencies were found with respect to the association between subnormal vitamin B12 concentrations and mean corpuscular volume (MCV).

Our own study appeared to be the only longitudinal study on the effect of low vitamin B12 concentrations (<150pmol/l) on developing anaemia.46 In our population-based sample of 85-year-old subjects, low vitamin B12 concentrations were not associated with an increased risk of having anaemia at baseline (prevalent anaemia) or developing anaemia during follow-up (incident anaemia). We found three randomised placebo-controlled trials with a total number of 210 participants that met the criteria for intervention studies for inclusion in our review.69–71 These three trials included patients with low or subnormal vitamin B12 concentrations at the start of the study. The first trial, by Hughes et al., included a random sample of 39 persons aged ≥65 years registered at general practices in a town in Wales, UK, who were treated for four weeks with intramuscular hydroxocobalamin or placebo. Haemoglobin was measured after five weeks.69 The second trial, by Hvas et al., included 140 persons in Aarhus, Denmark, with elevated methylmalonic acid concentrations (median age 75 years in the treatment group and 74 years in the placebo group), who received weekly intramuscular injections of cyanocobalamin or placebo for one month. Haemoglobin was measured after three months (13 weeks).70 In the third trial, by Seal et al., 31 persons in two geriatric hospitals in Melbourne, Australia, (mean age ≥78 years) received two doses of oral cyanocobalamin daily or placebo for four weeks.71 Owing to clinical heterogeneity (differences in methods of administration, dose of vitamin B12, outcome measures and treatment follow-up time), we did not combine the results in a metaanalysis. However, all three RCTs, which were regarded as high quality, showed no beneficial effects of vitamin B12 administration on haemoglobin concentrations, MCV, cognitive function and neurological symptoms.69–71 Neither was there any therapeutic effect in participants who were anaemic.70

Taking these findings into account, one may conclude that strong evidence of a positive association between subnormal vitamin B12 concentrations and anaemia in older persons in the general population is lacking.

Clinical Implications and Implications for Future Research
The findings mentioned above do not at all imply that patients with pernicious anaemia or malabsorption of vitamin B12 from food (with tissue depletion of vitamin B12 and very low vitamin B12 concentrations) should not receive vitamin B12 supplementation.31,32 However, apart from the undisputed case of pernicious anaemia, the clinical impact of subnormal vitamin B12 concentrations in older persons in the general population remains unclear. The fact that several observational studies and randomised controlled trials also showed no effect of vitamin B12 administration on cognitive function raises even more doubt about the consequences of subnormal vitamin B12 concentrations in older persons in the general population.72–74

Taking this into account, many older persons in primary care may receive vitamin B12 supplementation without evidence of clinical improvement. Although the cost of treatment with vitamin B12 in older individuals may be considered limited compared with other types of medical treatment, this does not justify initiation and continuation of treatment with vitamin B12 in older persons if not supported by medical evidence. These findings also raise doubt about the value of vitamin B12 measurements in diagnostic guidelines for anaemia as they may distract attention from other possible underlying causes. Additional proof of the (lack of) effectiveness of treatment with vitamin B12 in older patients with anaemia and subnormal vitamin B12 concentrations would be provided by a randomised double-blind placebo-controlled trial in which older patients with anaemia and subnormal vitamin B12 concentrations either receive usual care with vitamin B12 or placebo. However, before such a trial has been performed, the accumulating evidence suggests that clinicians should at least reconsider the risks of low vitamin B12 concentrations before starting cyanocobalamin or hydroxocobalamin supplementation in older individuals.75 The subnormal vitamin B12 concentrations may not be the cause of the anaemia, and supplementation with vitamin B12 may therefore not lead to a rise in haemoglobin concentrations.

Conclusion
Despite the undisputed case of pernicious anaemia, evidence of a positive association between subnormal serum vitamin B12 concentrations and anaemia in older persons is limited and inconclusive. If anything, given the high clinical relevance of anaemia in old age, we recommend more well-designed intervention studies of appropriate size and duration with timely follow-up periods to determine whether supplementation of older persons with subnormal vitamin B12 concentrations has a beneficial effect on haematological parameters. â– 

2

References

  1. Beghe C, Wilson A, Ershler WB, Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature, Am J Med, 2004;116(Suppl. 7A):3S–10S.
  2. Gaskell H, Derry S, Andrew MR, McQuay HJ, Prevalence of anaemia in older persons: systematic review, BMC Geriatr, 2008;8:1.
  3. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al., Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia, Blood, 2004;104(8):2263–8.
  4. Nutritional anaemias. Report of a WHO scientific group, World Health Organ Tech Rep Ser, 1968;405:5–37.
  5. Izaks GJ, Westendorp RG, Knook DL, The definition of anemia in older persons, JAMA, 1999;281(18):1714–7.
  6. den Elzen WP, Willems JM, Westendorp RG, et al., Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-plus Study, CMAJ, 2009;181(3–4):151–7.
  7. Chaves PH, Xue QL, Guralnik JM, et al., What constitutes normal hemoglobin concentration in community-dwelling disabled older women?, J Am Geriatr Soc, 2004;52(11):1811–6.
  8. Denny SD, Kuchibhatla MN, Cohen HJ, Impact of anemia on mortality, cognition, and function in community-dwelling elderly, Am J Med, 2006;119(4):327–34.
  9. Zakai NA, Katz R, Hirsch C, et al., A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study, Arch Intern Med, 2005;165(19):2214–20.
  10. Culleton BF, Manns BJ, Zhang J, et al., Impact of anemia on hospitalization and mortality in older adults, Blood, 2006;107(10):3841–6.
  11. Chaves PH, Functional outcomes of anemia in older adults, Semin Hematol, 2008;45(4):255–60.
  12. Beard CM, Kokmen E, O’Brien PC, et al., Risk of Alzheimer’s disease among elderly patients with anemia: populationbased investigations in Olmsted County, Minnesota, Ann Epidemiol, 1997;7(3):219–24.
  13. Chaves PH, Ashar B, Guralnik JM, Fried LP, Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated?, J Am Geriatr Soc, 2002;50(7):1257–64.
  14. Lipschitz D, Medical and functional consequences of anemia in the elderly, J Am Geriatr Soc, 2003;51(3 Suppl.):S10–3.
  15. Metivier F, Marchais SJ, Guerin AP, et al., Pathophysiology of anaemia: focus on the heart and blood vessels, Nephrol Dial Transplant, 2000;15(Suppl. 3):14–8.
  16. Onder G, Penninx BW, Cesari M, et al., Anemia is associated with depression in older adults: results from the InCHIANTI study, J Gerontol A Biol Sci Med Sci, 2005;60(9):1168–72.
  17. Penninx BW, Guralnik JM, Onder G, et al., Anemia and decline in physical performance among older persons, Am J Med, 2003;115(2):104–10.
  18. Penninx BW, Pahor M, Cesari M, et al., Anemia is associated with disability and decreased physical performance and muscle strength in the elderly, J Am Geriatr Soc, 2004;52(5):719–24.
  19. Penninx BW, Pluijm SM, Lips P, et al., Late-life anemia is associated with increased risk of recurrent falls, J Am Geriatr Soc, 2005;53(12):2106–11.
  20. Salive ME, Cornoni-Huntley J, Guralnik JM, et al., Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status, J Am Geriatr Soc, 1992;40(5):489–96.
  21. Eisenstaedt R, Penninx BW, Woodman RC, Anemia in the elderly: current understanding and emerging concepts, Blood Rev, 2006;20(4):213–26.
  22. Robinson B, Cost of anemia in the elderly, J Am Geriatr Soc, 2003;51(Suppl. 3):S14–7.
  23. Okuda K, Discovery of vitamin B12 in the liver and its absorption factor in the stomach: a historical review, J Gastroenterol Hepatol, 1999;14(4):301–8.
  24. Chanarin I, Historical review: a history of pernicious anaemia, Br J Haematol, 2000;111(2):407–15.
  25. Biermer A, [On a form of progressive pernicious anaemia], Schweiz Arzte, 1872;2:15–7.
  26. Minot GR, Murphy WP, Treatment of pernicious anemia by a special diet, JAMA, 1926;87:470–6.
  27. Lester-Smith E, Purification of the anti-pernicious anaemia factor from liver extracts, Nature, 1948;161:638–9.
  28. Rickes EL, Brink NG, Koniusky FR, et al., Crystalline vitamin B12, Science, 1948;107:396–7.
  29. Whittingham S, Mackay IR, Autoimmune gastritis: historical antecedents, outstanding discoveries, and unresolved problems, Int Rev Immunol, 2005;24(1-2):1–29.
  30. Mooney FS, Heathcote JG, Oral treatment of pernicious anaemia: first fifty cases, Br Med J, 1966;1(5496):1149–51.
  31. Andres E, Kaltenbach G, Noel E, et al., Efficacy of short-term oral cobalamin therapy for the treatment of cobalamin deficiencies related to food-cobalamin malabsorption: a study of 30 patients, Clin Lab Haematol, 2003;25(3):161–6.
  32. Bolaman Z, Kadikoylu G, Yukselen V, et al., Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study, Clin Ther, 2003;25(12):3124–34.
  33. Kuzminski AM, Del Giacco EJ, Allen RH, et al., Effective treatment of cobalamin deficiency with oral cobalamin, Blood, 1998;92(4):1191–8.
  34. Chan JC, Liu HS, Kho BC, et al., Pattern of thyroid autoimmunity in Chinese patients with pernicious anemia, Am J Med Sci, 2009;337(6):432–7.
  35. Stabler SP, Allen RH, Savage DG, Lindenbaum J, Clinical spectrum and diagnosis of cobalamin deficiency, Blood, 1990;76(5):871–81.
  36. Andres E, Loukili NH, Noel E, et al., Vitamin B12 (cobalamin) deficiency in elderly patients, CMAJ, 2004;171(3):251–9.
  37. Wolters M, Strohle A, Hahn A, Cobalamin: a critical vitamin in the elderly, Prev Med, 2004;39(6):1256–66.
  38. Babior BM, Bunn HF, Megaloblastic Anemias. In: Kasper DL, Braunwald E, Fauci AS, et al. (eds), Harrison’s Principles of Internal Medicine, 16th edn, New York, NY: McGraw-Hill, 2004;602–7.
  39. Kolnaar BGM, Van Wijk MAM, Pijnenborg L, Assendelft WJJ, [Summary of the Dutch College of General Practitioners’ practice guideline ‘anaemia’], Ned Tijdschr Geneeskd, 2003;147(40):1956–61.
  40. Pennypacker LC, Allen RH, Kelly JP, et al., High prevalence of cobalamin deficiency in elderly outpatients, J Am Geriatr Soc, 1992;40(12):1197–204.
  41. Clarke R, Refsum H, Birks J, et al., Screening for vitamin B-12 and folate deficiency in older persons, Am J Clin Nutr, 2003;77(5):1241–7.
  42. Stabler SP, Screening the older population for cobalamin (vitamin B12) deficiency, J Am Geriatr Soc, 1995;43(11):1290–7.
  43. Martens JH, Barg H, Warren MJ, Jahn D, Microbial production of vitamin B12, Appl Microbiol Biotechnol, 2002;58(3):275–85.
  44. Samson D, Halliday D, Chanarin I, Reversal of ineffective erythropoiesis in pernicious anaemia following vitamin B12 therapy, Br J Haematol, 1977;35(2):217–24.
  45. Myhre E, Studies on megaloblasts in vitro. I. Proliferation and destruction of nucleated red cells in pernicious anemia before and during treatment with vitamin B 12, Scand J Clin Lab Invest, 1964;16:307–19.
  46. den Elzen WP, Westendorp RG, Frolich M, et al., Vitamin B12 and folate and the risk of anemia in old age: the Leiden 85- Plus Study, Arch Intern Med, 2008;168(20):2238–44.
  47. den Elzen WP, van der Weele GM, Gussekloo J, et al., Subnormal vitamin B12 concentrations and anaemia in older people: a systematic review, BMC Geriatr, 2010;10:42.
  48. Clarke R, Sherliker P, Hin H, et al., Folate and vitamin B12 status in relation to cognitive impairment and anaemia in the setting of voluntary fortification in the UK, Br J Nutr, 2008;100(5):1054–9.
  49. Morris MS, Jacques PF, Rosenberg IH, Selhub J, Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification, Am J Clin Nutr, 2007;85(1):193–200.
  50. Wang YH, Yan F, Zhang WB, et al., An investigation of vitamin B12 deficiency in elderly inpatients in neurology department, Neurosci Bull, 2009;25(4):209–15.
  51. Allain TJ, Gomo Z, Wilson AO, et al., Anaemia, macrocytosis, vitamin B12 and folate levels in elderly Zimbabweans, Cent Afr J Med, 1997;43(11):325–8.
  52. Johnson MA, Hawthorne NA, Brackett WR, et al., Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using Title IIIc nutrition services, Am J Clin Nutr, 2003;77(1):211–20.
  53. McLennan WJ, Andrews GR, Macleod C, Caird FI, Anaemia in the elderly, Q J Med, 1973;42(165):1–13.
  54. Penninx BW, Guralnik JM, Ferrucci L, et al., Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women’s Health and Aging Study, Am J Psychiatry, 2000;157(5):715–21.
  55. Joosten E, Pelemans W, Hiele M, Goossens W, [Vitamin B12 (cobalamin)-deficiency in the elderly], Ned Tijdschr Geneeskd, 1990;134(13):652–6.
  56. Kwok T, Cheng G, Woo J, et al., Independent effect of vitamin B12 deficiency on hematological status in older Chinese vegetarian women, Am J Hematol, 2002;70(3):186–90.
  57. Prayurahong B, Tungtrongchitr R, Chanjanakijskul S, et al., Vitamin B12, folic acid and haematological status in elderly Thais, J Med Assoc Thai, 1993;76(2):71–8.
  58. Bjorkegren K, Svardsudd K, Serum cobalamin, folate, methylmalonic acid and total homocysteine as vitamin B12 and folate tissue deficiency markers amongst elderly Swedes – a population-based study, J Intern Med, 2001;249(5):423–32.
  59. Hin H, Clarke R, Sherliker P, et al., Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 study, Age Ageing, 2006;35(4):416–22.
  60. Hvas AM, Nexo E, Holotranscobalamin – a first choice assay for diagnosing early vitamin B deficiency?, J Intern Med, 2005;257(3):289–98.
  61. Lippi G, Montagnana M, Targher G, Guidi GC, Vitamin B12, folate, and anemia in old age, Arch Intern Med, 2009;169(7):716.
  62. Loikas S, Koskinen P, Irjala K, et al., Vitamin B12 deficiency in the aged: a population-based study, Age Ageing, 2007;36(2):177–83.
  63. Bisbe E, Castillo J, Saez M, et al., Prevalence of preoperative anemia and hematinic deficiencies in patients scheduled for elective major orthopedic surgery, Transfus Altern Transfus Med, 2008;10(4):166–73.
  64. Chui CH, Lau FY, Wong R, et al., Vitamin B12 deficiency – Need for a new guideline, Nutrition, 2001;17(11–2):917–20.
  65. Metz J, Bell AH, Flicker L, et al., The significance of subnormal serum vitamin B12 concentration in older people: a case control study, J Am Geriatr Soc, 1996;44(11):1355–61.
  66. Mooney KM, Young IS, Patterson CC, Cuskelly GJ, Vitamin B12 status in elderly subjects with low haemoglobin, Proc Nutr Soc, 2004;63:77A.
  67. Stott DJ, Langhorne P, Hendry A, et al., Prevalence and haemopoietic effects of low serum vitamin B12 levels in geriatric medical patients, Br J Nutr, 1997;78(1):57–63.
  68. Witte KK, Desilva R, Chattopadhyay S, et al., Are hematinic deficiencies the cause of anemia in chronic heart failure?, Am Heart J, 2004;147(5):924–30.
  69. Hughes D, Elwood PC, Shinton NK, Wrighton RJ, Clinical trial of the effect of vitamin B12 in elderly subjects with low serum B12 levels, Br Med J, 1970;1(5707):458–60.
  70. Hvas AM, Ellegaard J, Nexo E, Vitamin B12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebo-controlled study, Clin Chem, 2001;47(8):1396–404.
  71. Seal EC, Metz J, Flicker L, Melny J, A randomized, doubleblind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations, J Am Geriatr Soc, 2002;50(1):146–51.
  72. Mooijaart SP, Gussekloo J, Frolich M, et al., Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus Study, Am J Clin Nutr, 2005;82(4):866–71.
  73. Ellinson M, Thomas J, Patterson A, A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly, J Hum Nutr Diet, 2004;17(4):371–83.
  74. Malouf R, Areosa SA, Vitamin B12 for cognition, Cochrane Database Syst Rev, 2003;(3):CD004326.
  75. den Elzen WP, Westendorp RG, Frolich M, et al., Role of Vitamin B12 in Anemia in Old Age – In reply, Arch Intern Med, 2009;169(12):168.
3

Article Information

Disclosure

The authors have no conflicts of interest to declare.

Correspondence

Wendy PJ den Elzen, Department of Public Health and Primary Care, Leiden University Medical Centre, Post zone V-0-P, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E: w.p.j.den_elzen@lumc.nl

Received

2011-01-27T00:00:00

4

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
10 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Cell-based Genetic Therapy for the Induction of Foetal Haemoglobin in Sickle Cell Disease and Transfusion-dependent β-thalassaemia

Martin H Steinberg

Mutations of the β-globin gene (HBB) cause sickle cell disease and β-thalassaemia, collectively named the β-haemoglobinopathies. As mankind’s most common severe genetic diseases, where they are most prevalent, public health systems can be stressed.1–3 Asymptomatic heterozygous carriers are protected from severe P. falciparum infection. This has allowed the causative genes to reach polymorphic frequencies in some tropical […]

touchREVIEWS in Oncology & Haematology. 2023;19(2):29-32
Advertisement
    • 5

    Related Content in Haematology

    Latest articles videos and clinical updates - straight to your inbox

    Close Popup